Funding for this research was provided by:
Instituto de Salud Carlos III (CP19/00031)
Foundation for the National Institutes of Health (U01 AG024904)
U.S. Department of Defense (W81XWH-12-2-0012)
Received: 29 October 2020
Accepted: 3 February 2021
First Online: 19 February 2021
Change Date: 10 April 2021
Change Type: Update
Change Details: The paper was amended to add the OA funding note.
Ethics approval and consent to participate
: Data collection and sharing in ADNI was approved by the Institutional Review Board of each participating institution. All procedures involving human participants were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all ADNI participants and/or authorized representatives before any protocol-specific procedures were carried out.
: Not applicable.
: SJT participated in the scientific advisory boards of Roche Pharma AG and MSD and received lecture fees from Roche and MSD. MJG, FL, CL, MD, EW and RB declare that they have no competing interests.